Details of the Drug

General Information of Drug (ID: DM835LV)

Drug Name

NGR-TNF

Indication

Disease Entry	ICD 11	Status	REF
Mesothelioma	2C51.2	Phase 3	[1]
------------------------------------------------------------------------------------

Drug Type

Fusion protein

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01098266) NGR015: Randomized Double-blind Phase III Study of NGR-hTNF Plus Best Investigator's Choice (BIC) Versus Placebo Plus BIC in Previously Treated Patients With Advanced Malignant Pleural Mesothelioma (MPM). U.S.National Institutes of Health.